Factors influencing the time to surgery after neoadjuvant chemotherapy in breast cancer patients

被引：0
|
作者：
Carolin Müller
Ingolf Juhasz-Böss
Gilda Schmidt
Peter Jungmann
Erich-Franz Solomayer
Georg-Peter Breitbach
Stephanie Juhasz-Böss
机构：
[1] Saarland University Medical Center,Department of Gynecology, Obstetrics and Reproductive Medicine
来源：
Archives of Gynecology and Obstetrics | 2020年 / 301卷
关键词：
Breast cancer; Neoadjuvant therapy; Time to surgery; Delaying factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1055 / 1059
页数：4
相关论文
共 50 条
  • [21] Breast surgery after neoadjuvant chemotherapy
    Houvenaeghel, Gilles
    Cohen, Monique
    Lambaudie, Eric
    Bannier, Marie
    Buttarelli, Max
    [J]. BULLETIN DU CANCER, 2011, 98 (01) : 19 - 24
  • [22] Time from completion of neoadjuvant chemotherapy to surgery: Effects on outcomes in breast cancer patients
    Buhariwalla, Karen
    Arciero, Cletus
    Subhedar, Preeti
    Torres, Mylin
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : 136 - 137
  • [23] NATURAL IMMUNITY IN BREAST-CANCER PATIENTS DURING NEOADJUVANT CHEMOTHERAPY AND AFTER SURGERY
    BEITSCH, P
    LOTZOVA, E
    HORTOBAGYI, G
    POLLOCK, R
    [J]. SURGICAL ONCOLOGY-OXFORD, 1994, 3 (04): : 211 - 219
  • [24] Factors Influencing the Onset of Neoadjuvant Therapy in Breast Cancer Patients
    Mueller, Carolin
    Juhasz-Boess, Stephanie
    Schmidt, Gilda
    Solomayer, Erich-Franz
    Juhasz-Boess, Ingolf
    Breitbach, Georg-Peter
    [J]. BREAST CARE, 2020, 15 (02) : 182 - 187
  • [25] Prognostic factors after neoadjuvant chemotherapy in breast cancer: Surgery type as a new prognostic factor
    Fujihara, M.
    Kin, T.
    Yoshimura, Y.
    Kajiwara, Y.
    Ito, M.
    Abe, K.
    Sakata, Y.
    Hiraki, K.
    Ohtani, S.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [26] Prognostic factors after neoadjuvant chemotherapy in breast cancer: Surgery type as a new prognostic factor
    Fujihara, M.
    Kin, T.
    Yoshimura, Y.
    Kajiwara, Y.
    Ito, M.
    Ohtani, S.
    [J]. CANCER RESEARCH, 2017, 77
  • [27] Predictive Factors of Complete Axillary Downstaging after Neoadjuvant Chemotherapy in Breast Cancer Patients
    Vidal, M.
    Perez-Garcia, J. M.
    Munoz, E.
    Saura, C.
    de Mattos, L.
    Gomez, P.
    Cortes, J.
    Baselga, J.
    Bellet, M.
    [J]. CANCER RESEARCH, 2010, 70
  • [28] Prognostic factors in breast cancer patients following neoadjuvant chemotherapy
    Kim, JR
    Chang, ES
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 : S395 - S396
  • [29] Prognostic factors in breast cancer patients following neoadjuvant chemotherapy
    Kim, J.
    Lee, J.
    Kim, H.
    Chang, E.
    [J]. BREAST, 2007, 16 : S29 - S29
  • [30] Time to surgery after completion of neoadjuvant chemotherapy does not negatively impact recurrence and survival outcomes in breast cancer patients
    Bek, S.
    Du De Xuan, S.
    Sultana, R.
    Tan, Q. T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 175 : S27 - S27
12345